脂肪因子,Adipokine
1)Adipokine脂肪因子
1.Study Progress of Adipokine Apelin;脂肪因子Apelin研究进展
2.A New Adipokine Chemerin脂肪因子chemerin研究进展
3.Adipose tissue can secrete a variety of bioactive substances called adipokines including leptin,resistin,adiponectin,visfatin,TNFα,PAI-1,and IL-6.脂肪因子是一系列由脂肪组织分泌的生物活性物质,包括瘦素、抵抗素、脂联素、内肥素、肿瘤坏死因子、纤溶酶原激活物抑制因子和白介素-6等。
英文短句/例句

1.A novel adipokine-Chemerin一种新的脂肪因子——Chemerin
2.A New Adipokine Chemerin脂肪因子chemerin研究进展
3.Progresses about Adipokines and Nonalcoholic Fatty Liver Disease脂肪因子与非酒精性脂肪性肝病研究进展
4.Associativity of Adipocytokin Visfatin with Metabolic Syndrome脂肪因子visfatin与代谢综合征的相关性
5.Visfatin:a Adipo- cytokin Discovered RecentlyVisfatin——一种新发现的脂肪因子
6.Effects of Berberine on Cell Proliferation, Differentiation, Apoptosis and Adipocytines Expression in 3T3-L1 Adipocytes;小檗碱对3T3-L1脂肪细胞增殖、分化、凋亡及脂肪因子的影响
7.Research about Adipocytokines and Metabolic Syndrome;代谢综合征患者脂肪因子的变化及意义
8.Roles of adipocytokines in the pathogenesis of non-alcoholic fatty liver disease脂肪细胞因子在非酒精性脂肪性肝病中的作用
9.A Study on the Mutations in Exon 9 of LPL Gene;脂蛋白脂肪酶基因外显子9基因突变的研究
10.A Study on the Mutations in Exon 5~9 of LPL Gene;脂蛋白脂肪酶基因外显子5~9基因突变的研究
11.Kruppel-like Factors(KLFs)and Adipocyte DifferentiationKLF转录因子家族与脂肪细胞分化
12.The Action of Adipocytokines in Regulating Organisms Energy Metabolism and Fat Accumulation;脂肪细胞因子对机体能量代谢及脂肪积累的调节
13.Recent advances in understanding the relationship of adipocytokines with non-alcoholic fatty liver disease and insulin resistance脂肪细胞因子与非酒精性脂肪肝和胰岛素抵抗关系的研究进展
14.The effect of environmental factors on the content of fatty acids composites and total fatty acids yield of heterotrophic Chlorella vulgaris环境因子对异养小球藻脂肪酸组分含量和脂肪总酸产量的影响
15.The Relationship of Morphological Characters,Crude Fat of Jatropha curcas (Euphorbiaceae) Seed with Environmental Factors膏桐种子形态、粗脂肪含量与环境因子关系
16.The Relationship of Adipocytokines with Obesity and Diabetes, and Studies on Expression and Intervention of Adiponectin and Adiponectin-receptor in Human Adipocytes;脂肪细胞因子与肥胖和糖尿病的关系及人脂肪细胞中脂联素及其受体表达和干预的研究
17.Roles of Adipocytokines and Adiponectin Receptor in Pathogenesis of Nonalcoholic Fatty Liver Disease in Rats;脂肪细胞因子及脂联素受体在大鼠非酒精性脂肪性肝病发病中的作用研究
18.The Study on the Effects of Angiotensin Ⅱ Receptor Blockers on the Proinflammatory Factors' Secretion and Metabolisms of Glucose and Lipid of the Adipose Tissue and the Adipocytes血管紧张素Ⅱ受体拮抗剂对脂肪组织和脂肪细胞糖脂代谢及炎症因子的影响
相关短句/例句

adipokines脂肪因子
1.Serum Adipokines and Ghrelin in non-alcoholic fatty liver;非酒精性脂肪肝患者脂肪因子与Ghrelin血清学检测及临床意义
2.Progresses about Adipokines and Nonalcoholic Fatty Liver Disease脂肪因子与非酒精性脂肪性肝病研究进展
3.In this review, we propose that adipokines influence β-cell function through three inter- dependent pathways.脂肪因子包括脂肪细胞分泌的多种活性因子,它们通过内分泌方式调节胰岛β细胞的胰岛素分泌、基因表达以及细胞凋亡等多方面的功能。
3)adipocyte factor脂肪因子
1.Correlation Analysis of Interventional Effects Of Exercise Therapy on Levels Of Adipocyte Factor in Patients with Newly Diagnosed Type 2 Diabetes Mellitus运动疗法干预初诊2型糖尿病患者脂肪因子的相关性分析
2.Objective To discuss the relationship between adipocyte factor,which be represented by leptin,resistin and adiponectin,and metabolic syndrome.目的探讨以血清瘦素、抵抗素和脂联素为代表的脂肪因子与代谢综合征的关系。
3.This essay explores the effect of aerobic exercise on adipocyte factor expression in high-fat diet fed SD rats and its relationship to insulin resistance.探讨运动对高脂饮食诱导的肥胖SD大鼠胰岛素敏感性和部分脂肪因子表达的影响。
4)Adipocytokines脂肪因子
1.Adipocytokines and non-alcoholic fatty liver disease;脂肪因子与非酒精性脂肪肝
5)adipocytokine脂肪因子
1.Aside from classic risk factors such as hyperlipidaemia and insulin resistance,recent studies have demonstrated that systematic inflammation and adipocytokines,such as leptin, adiponectin and resistin,may play important roles in the development of IR and atherosclerosis.胰岛素抵抗(IR)、脂代谢紊乱等在慢性肾脏病(CKD)患者中常见,是影响心血管疾病的重要因素;系统性炎症、脂肪因子等非传统危险因素也在CKD患者心脑血管疾病的发病中起一定作用。
6)Adipokine脂肪细胞因子
1.Advance on adipose tissue and adipokines;脂肪组织和脂肪细胞因子的研究进展
延伸阅读

正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂